229 related articles for article (PubMed ID: 22351245)
1. MRI findings of inflammatory breast cancer, locally advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast cancer.
Uematsu T
Breast Cancer; 2012 Oct; 19(4):289-94. PubMed ID: 22351245
[TBL] [Abstract][Full Text] [Related]
2. Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.
Li BD; Sicard MA; Ampil F; Abreo F; Lilien D; Chu QD; Burton GV
Oncology; 2010; 79(1-2):3-12. PubMed ID: 21051912
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory breast carcinoma in magnetic resonance imaging: a comparison with locally advanced breast cancer.
Renz DM; Baltzer PA; Böttcher J; Thaher F; Gajda M; Camara O; Runnebaum IB; Kaiser WA
Acad Radiol; 2008 Feb; 15(2):209-21. PubMed ID: 18206620
[TBL] [Abstract][Full Text] [Related]
4. Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis.
Resetkova E
Semin Oncol; 2008 Feb; 35(1):25-32. PubMed ID: 18308143
[TBL] [Abstract][Full Text] [Related]
5. Case report of bilateral inflammatory breast cancer.
Masannat YA; Peter M; Turton P; Shaaban AM
Eur J Cancer Care (Engl); 2010 Jul; 19(4):558-60. PubMed ID: 19708943
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory breast cancer: challenges and developments.
Ferrara AR
Radiol Technol; 2008 Sep; 80(1):49M-60M; quiz 61M-63M. PubMed ID: 18796566
[TBL] [Abstract][Full Text] [Related]
7. Skin thickening as unique pathologic sign of an inflammatory breast cancer: a case report and review of the literature.
Ballesio L; D'Ambrosio I; Ravazzolo N; Angeletti M; Di Pastena F; Tardioli S; Lodise P; Marini M
Clin Ter; 2011; 162(4):351-4. PubMed ID: 21912823
[TBL] [Abstract][Full Text] [Related]
8. Can T2-weighted 3-T breast MRI predict clinically occult inflammatory breast cancer before pathological examination? A single-center experience.
Uematsu T; Kasami M; Watanabe J
Breast Cancer; 2014 Jan; 21(1):115-21. PubMed ID: 23104394
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging features of inflammatory breast metastasis from gastric signet-ring cell carcinoma.
Kim SJ
Clin Imaging; 2013; 37(3):569-73. PubMed ID: 23068056
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from an unusual case of inflammatory breast cancer.
Harrison AM; Zendejas B; Ali SM; Scow JS; Farley DR
J Surg Educ; 2012; 69(3):350-4. PubMed ID: 22483137
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study.
Renz DM; Baltzer PA; Böttcher J; Thaher F; Gajda M; Camara O; Runnebaum IB; Kaiser WA
Eur Radiol; 2008 Nov; 18(11):2370-80. PubMed ID: 18523781
[TBL] [Abstract][Full Text] [Related]
12. Differentiating inflammatory breast cancer from acute mastitis.
Dahlbeck SW; Donnelly JF; Theriault RL
Am Fam Physician; 1995 Sep; 52(3):929-34. PubMed ID: 7653430
[TBL] [Abstract][Full Text] [Related]
13. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
Fornasa F; Nesoti MV; Bovo C; Bonavina MG
J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin B: a potential prognostic marker for inflammatory breast cancer.
Nouh MA; Mohamed MM; El-Shinawi M; Shaalan MA; Cavallo-Medved D; Khaled HM; Sloane BF
J Transl Med; 2011 Jan; 9():1. PubMed ID: 21199580
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results.
Luciani A; Dao TH; Lapeyre M; Schwarzinger M; Debaecque C; Lantieri L; Revelon G; Bouanane M; Kobeiter H; Rahmouni A
AJR Am J Roentgenol; 2004 Apr; 182(4):1059-67. PubMed ID: 15039188
[TBL] [Abstract][Full Text] [Related]
17. Evolving role of imaging modalities in inflammatory breast cancer.
Le-Petross CH; Bidaut L; Yang WT
Semin Oncol; 2008 Feb; 35(1):51-63. PubMed ID: 18308146
[TBL] [Abstract][Full Text] [Related]
18. Potential MRI interpretation model: differentiation of benign from malignant breast masses.
Malich A; Fischer DR; Wurdinger S; Boettcher J; Marx C; Facius M; Kaiser WA
AJR Am J Roentgenol; 2005 Oct; 185(4):964-70. PubMed ID: 16177416
[TBL] [Abstract][Full Text] [Related]
19. Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity.
Junping W; Tongguo S; Yunting Z; Chunshui Y; Renju B
J Magn Reson Imaging; 2012 Sep; 36(3):624-31. PubMed ID: 22570219
[TBL] [Abstract][Full Text] [Related]
20. Tuberculous adenopathy masquerading as locally advanced breast cancer.
Walsh N; Greene J; Catherine Lee M
Breast J; 2013; 19(1):106-7. PubMed ID: 23279334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
